The Board of Directors of the Company has considered and approved Un-audited Standalone Provisional Financial Results together with the Limited Review Report from Statutory Auditors of the Company for Quarter ended on 30.06.2018. Further,the Board of Directors also decided as follows: 1. The 43rd Annual General Meeting of the Company will be held on Thursday, 27th September, 2018 at Guwahati, Assam. 2. The Closure of Register of Members and Share Transfer Books of the Company will be from 17th September, 2018 to 27th September, 2018 (both days inclusive) for the purpose of Equity Dividend, recommended by the Board at its previous meeting held on 30th May, 2018 and for Annual General Meeting. If approved at the 43rd AGM, the dividend shall be paid on or after 28th September, 2018. 3. The options for capacity additions to its existing Alkyl Alkonolamines, Morpholine and its derivatives multiproduct Plant and to appoint Consultants / Agencies to study and submit feasibility reports.
Source : BSE - www.bseindia.com
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.